PD-L1 antibody decorated chemiluminescence producing Au-Ag nanoalloys for targeted detection of hepatic cancer cells
Colloids and Surfaces B: Biointerfaces · 2026
DOI: 10.1016/j.colsurfb.2025.115249 ↗Kurz gefasst
Fachartikel in der Zeitschrift Colloids and Surfaces B: Biointerfaces, 2026. Verfasst von Stuti Bhagat und 3 weiteren Autor:innen. Beteiligte Einrichtung: Nanobiology and Nanozymology Research Laboratory, National Institute of Animal Biotechnology (NIAB), Opposite Journalist Colony, Near Gowlidoddy, Ext…. Hauptthemen laut MEDLINE: Gold, B7-H1 Antigen, Silver, Liver Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: University Grants Commission, Indian Council of Medical Research.
Abstract (Originalsprache)
Early cancer diagnosis is vital for improving patient survival, enabling real-time treatment monitoring, and reducing mortality. Chemiluminescence (CL)-based detection systems offer a promising alternative to conventional diagnostic techniques due to their high sensitivity, lack of excitation light requirements, and reduced light scattering by biological tissues, making them particularly suitable for rapid and precise cancer diagnostics. In this study, we report the synthesis and application of PD-L1 antibody-conjugated gold-silver (Au:Ag) nanoalloys as CL signal enhancers for the targeted detection of hepatic cancer cells. Dextran-coated Au:Ag nanoalloys were synthesized in varying molar ratios (3:1, 1:1, and 1:3) to optimize their physicochemical and catalytic properties. The PD-L1 antibody was covalently functionalized onto the surface of the Au:AgNPs (1:3) formulation via Schiff base chemistry. Among the different compositions, the Au:AgNPs (1:3) produced the most intense CL signal, attributed to their superior catalytic activity in H2O2 decomposition, thereby enhancing luminol oxidation. Additionally, the PD-L1 antibody-functionalized Au:AgNPs (1:3) exhibited concentration-dependent CL signal enhancement in biological buffers. Importantly, these nanoalloys demonstrated significantly stronger association with HepG2 (hepatic cancer cells) compared to WRL-68 (hepatic normal cells), indicating selective targeting through PD-L1 antibody-ligand interactions. These findings highlight the potential of PD-L1 antibody-functionalized Au:AgNPs as a CL signal enhancer and for the selective identification of early-stage cancer cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nanobiology and Nanozymology Research Laboratory, National Institute of Animal Biotechnology (NIAB), Opposite Journalist Colony, Near Gowlidoddy, Extended Q-City Road, Gachibowli, Hyderabad, Telangana 500032, India.
- Nanobiology and Nanozymology Research Laboratory, National Institute of Animal Biotechnology (NIAB), Opposite Journalist Colony, Near Gowlidoddy, Extended Q-City Road, Gachibowli, Hyderabad, Telangana 500032, India. Ele…
Förderung
- University Grants Commission
- Indian Council of Medical Research
Zitieren
APA
Bhagat, S., Arora, P., Babu, K., & Singh, S. (2026). PD-L1 antibody decorated chemiluminescence producing Au-Ag nanoalloys for targeted detection of hepatic cancer cells. Colloids and Surfaces B: Biointerfaces. https://doi.org/10.1016/j.colsurfb.2025.115249
Vancouver
Bhagat S, Arora P, Babu K, Singh S. PD-L1 antibody decorated chemiluminescence producing Au-Ag nanoalloys for targeted detection of hepatic cancer cells. Colloids and Surfaces B: Biointerfaces. 2026. doi:10.1016/j.colsurfb.2025.115249
BibTeX
@article{Bhagat2026,
author = {Bhagat, Stuti and Arora, Palak and Babu, Keerthana and Singh, Sanjay},
title = {PD-L1 antibody decorated chemiluminescence producing Au-Ag nanoalloys for targeted detection of hepatic cancer cells},
journal = {Colloids and Surfaces B: Biointerfaces},
year = {2026},
doi = {10.1016/j.colsurfb.2025.115249}
}
EUVIMED